HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 337-348 of 1,811
Behavioral study icon
CompletedNCT05869253

The Efficacy of Equine Assisted Occupational Therapy for Children With Attention Deficit Hyperactivity Disorder (ADHD) on Cognitive-emotional Aspects, Daily Function and Participation

Official study title

The Efficacy of Attention Skill Therapy (ASTride), an Equine Assisted Occupational Therapy Intervention, for Children With Attention Deficit Hyperactivity Disorder (ADHD) on Cognitive-emotional Aspects, Daily Function and Participation

This study has finished and is no longer accepting participants.

In Tel Aviv
ADHDBehavioural studyAges 6–12
Countries
Israel
Sponsor
Tel Aviv University
Drug study icon
TerminatedNCT02477748

MDX 1400 mg Daily Compared With Placebo for ADHD

Official study title

A 10-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MDX (Metadoxine Immediate-release/Slow-release, Bilayer Tablet) 1400 mg Compared With Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

This study ended early.

Multiple locations, including Dothan
ADHDMedication studyAges 18–55
Countries
United States, Israel
Sponsor
Alcobra Ltd.
Drug study icon
CompletedNCT01269463

Time Course of Response to Methylphenidate HCl ER Capsules in Children 6 to 12 Years With ADHD in Classroom Setting

Official study title

A Randomized, Double-Blind Study of the Time Course of Response to Biphentin® Methylphenidate Hydrochloride ER Capsules Compared to Placebo in Children 6 to 12 Years With Attention Deficit Hyperactivity Disorder in Analog Classroom Setting

This study has finished and is no longer accepting participants.

In Irvine
ADHDMedication studyAges 6–12
Countries
United States
Sponsor
Rhodes Pharmaceuticals, L.P.
Drug study icon
CompletedNCT00997984

Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study)

Official study title

A Phase 3, Double-blind, Randomized, Multicenter, Placebo-controlled, Dose Optimization Study Evaluating the Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children Aged 6-12 With a Diagnosis of Attention-Deficit/Hyperactivity Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
ADHDMedication studyAges 6–12
Countries
United States, Canada
Sponsor
Shire
Behavioral study icon
CompletedNCT02489279

Training Attentional Awareness and Control in ADHD

Official study title

Training Attentional Awareness and Control in Attention Deficit Hyperactivity Disorder (ADHD)

This study has finished and is no longer accepting participants.

In Los Angeles
ADHDBehavioural studyAges 18–40
Countries
United States
Sponsor
Think Now Incorporated
Other study type icon
CompletedNCT02226445

Treatment Drop-out and Missed Appointments Among Adults With ADHD

Official study title

Treatment Drop-out and Missed Appointments Among Adults With Attention-Deficit/Hyperactivity Disorder: Associations With Patient- and Disorder-related Factors

This study has finished and is no longer accepting participants.

In Herning
ADHDObservational studyAges 18–64
Countries
Denmark
Sponsor
University of Aarhus

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.